Literature DB >> 21061440

B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis.

Keith M Hamel1, Yanxia Cao, Yumei Wang, Rachel Rodeghero, Tamas Kobezda, Lieping Chen, Alison Finnegan.   

Abstract

The immune system has developed several regulatory mechanisms to maintain homeostasis of adaptive immune responses. T-cell programmed death (PD)-1 recognition of B7-H1 (PD-L1) expressed on APC and non-lymphoid tissue regulates T-cell activation. We show that B7-H1(-/-) mice exhibit exacerbated proteoglycan (PG)-induced arthritis and increased Th-1 CD4(+) T-cell responses. Unexpectedly, the PG-specific antibody response in B7-H1(-/-) mice was diminished. A reduction in the number of peanut agglutinin(+) GC coincided with a decrease in CD19(+) GL-7(+) CD95(+) GC B cells that was a result of increased caspase-induced apoptosis. The percent of CD38(+) CD138(+) emerging plasma cells was decreased. B7-H1(-/-) mice exhibited an increased frequency of CD4(+) PD-1(hi) CXCR5(hi) ICOS(hi) CD62L(lo) T follicular helper cells that displayed a hyperactive phenotype with increased expression of mRNA transcripts for Bcl6, IL-21, and the apoptosis-inducer molecule FasL. In cell transfer of B7-H1(-/-) cells into SCID mice, non-B and non-T cells were sufficient to normalize the antibody response, T-cell hyperactivity, and the development of PG-induced arthritis. These findings indicate that B7-H1 on non-B and non-T cells signals through PD-1 on T effector cells to prevent excessive activation and reduce autoimmune arthritis. Furthermore, these findings demonstrate a novel role for B7-H1 expression in promoting B-cell survival by regulating the activation of T follicular helper cell.
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21061440      PMCID: PMC3638795          DOI: 10.1002/eji.201040690

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  44 in total

Review 1.  Germinal centres: role in B-cell physiology and malignancy.

Authors:  Ulf Klein; Riccardo Dalla-Favera
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

Review 2.  T follicular helper (TFH) cells in normal and dysregulated immune responses.

Authors:  Cecile King; Stuart G Tangye; Charles R Mackay
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

3.  PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.

Authors:  Laura L Carter; Michael W Leach; Mihai L Azoitei; Junqing Cui; Jeffrey W Pelker; Jason Jussif; Steve Benoit; Gretchen Ireland; Deborah Luxenberg; G Roger Askew; Kim L Milarski; Christopher Groves; Tom Brown; Brenda A Carito; Karen Percival; Beatriz M Carreno; Mary Collins; Suzana Marusic
Journal:  J Neuroimmunol       Date:  2006-12-19       Impact factor: 3.478

Review 4.  Immunologic mechanisms in the pathogenesis of rheumatoid arthritis.

Authors:  Gary S Firestein
Journal:  J Clin Rheumatol       Date:  2005-06       Impact factor: 3.517

5.  PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.

Authors:  LauraL Carter; Lynette A Fouser; Jason Jussif; Lori Fitz; Bija Deng; Clive R Wood; Mary Collins; Tasuku Honjo; Gordon J Freeman; Beatriz M Carreno
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

6.  Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity.

Authors:  Keith Hamel; Paul Doodes; Yanxia Cao; Yumei Wang; Jeffrey Martinson; Robert Dunn; Marilyn R Kehry; Balint Farkas; Alison Finnegan
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.

Authors:  Julia Menke; Julie A Lucas; Geraldine C Zeller; Mary E Keir; Xiao R Huang; Naotake Tsuboi; Tanya N Mayadas; Han Y Lan; Arlene H Sharpe; Vicki R Kelley
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

Review 8.  Sites and stages of autoreactive B cell activation and regulation.

Authors:  Mark J Shlomchik
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

9.  PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

Authors:  Xuemei Zhong; Joseph R Tumang; Wenda Gao; Chunyan Bai; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

10.  Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

Authors:  Manish J Butte; Mary E Keir; Theresa B Phamduy; Arlene H Sharpe; Gordon J Freeman
Journal:  Immunity       Date:  2007-07-12       Impact factor: 31.745

View more
  39 in total

Review 1.  Cell surface signaling molecules in the control of immune responses: a tide model.

Authors:  Yuwen Zhu; Sheng Yao; Lieping Chen
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

2.  Immune Regulation of sickle Cell Alloimmunization.

Authors:  Karina Yazdanbakhsh; Beth H Shaz; Christopher D Hillyer
Journal:  ISBT Sci Ser       Date:  2016-11-15

Review 3.  The regulation and role of T follicular helper cells in immunity.

Authors:  Elissa K Deenick; Cindy S Ma
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

4.  Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1.

Authors:  Kiyoshi Hirahara; Kamran Ghoreschi; Xiang-Ping Yang; Hayato Takahashi; Arian Laurence; Golnaz Vahedi; Giuseppe Sciumè; Aisling O'Hara Hall; Christopher D Dupont; Loise M Francisco; Qian Chen; Masao Tanaka; Yuka Kanno; Hong-Wei Sun; Arlene H Sharpe; Christopher A Hunter; John J O'Shea
Journal:  Immunity       Date:  2012-06-21       Impact factor: 31.745

5.  The expression and distribution of immunomodulatory proteins B7-H1, B7-DC, B7-H3, and B7-H4 in rheumatoid synovium.

Authors:  Guoning Guo; Yongjun Shang; Guoyan Zhu; Xiaoren Bao; Shiwei Xu; Yongwen Chen
Journal:  Clin Rheumatol       Date:  2011-07-22       Impact factor: 2.980

6.  Analysis of PD-1 and Tim-3 expression on CD4+ T cells of patients with rheumatoid arthritis; negative association with DAS28.

Authors:  Zohreh Koohini; Hadi Hossein-Nataj; Maryam Mobini; Aref Hosseinian-Amiri; Alireza Rafiei; Hossein Asgarian-Omran
Journal:  Clin Rheumatol       Date:  2018-04-07       Impact factor: 2.980

7.  The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood.

Authors:  Peter T Sage; Loise M Francisco; Christopher V Carman; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2012-12-16       Impact factor: 25.606

Review 8.  The good, the bad and the ugly - TFH cells in human health and disease.

Authors:  Stuart G Tangye; Cindy S Ma; Robert Brink; Elissa K Deenick
Journal:  Nat Rev Immunol       Date:  2013-05-17       Impact factor: 53.106

9.  High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways.

Authors:  Ze Xiu Xiao; Xiaojiang Hu; Ximei Zhang; Zhigang Chen; Julie Wang; Ke Jin; Feng Lin Cao; Baoqing Sun; Joseph A Bellanti; Nancy Olsen; Song Guo Zheng
Journal:  Signal Transduct Target Ther       Date:  2020-04-10

10.  Program Death-1 Suppresses Autoimmune Arthritis by Inhibiting Th17 Response.

Authors:  Lifen Yang; Guilin Qiao; Yassir Hassan; Zhenping Li; Xiaoqing Zhang; Huimin Kong; Weimin Zeng; Fei Yin; Jian Zhang
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-05-19       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.